Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lechner

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Rhinology|May 27, 2023
Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiativeC Philpott, K Kumaresan, A W Fjaeldstad, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2016
IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA NephropathySebastian M Lechner, Lilia Abbad, Erwan Boedec, et al.
The New England Journal of Medicine|August 2, 2023
Selective Inhibition of Na<sub>V</sub>1.8 with VX-548 for Acute PainJim Jones, Darin J Correll, Sandra M Lechner, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
Trends in Ecology & Evolution|June 11, 2020
Horizon Scan of the Belt and Road InitiativeAlice C Hughes, Alex M Lechner, Alexander Chitov, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Science (New York, N.Y.)|January 15, 2026
A theory of change approach to enhance the post-2030 sustainable development agendaCameron Allen, Shirin Malekpour, Nina Weitz, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXiaohu Zhang, Jaimie K Rueter, Yongsheng Chen, et al.
Journal of Medicinal Chemistry|January 15, 2008
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacyDeborah H Slee, Xiaohu Zhang, Manisha Moorjani, et al.
Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituentsDeborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Rhinology|May 27, 2023
Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiativeC Philpott, K Kumaresan, A W Fjaeldstad, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2016
IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA NephropathySebastian M Lechner, Lilia Abbad, Erwan Boedec, et al.
The New England Journal of Medicine|August 2, 2023
Selective Inhibition of Na<sub>V</sub>1.8 with VX-548 for Acute PainJim Jones, Darin J Correll, Sandra M Lechner, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
Trends in Ecology & Evolution|June 11, 2020
Horizon Scan of the Belt and Road InitiativeAlice C Hughes, Alex M Lechner, Alexander Chitov, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Science (New York, N.Y.)|January 15, 2026
A theory of change approach to enhance the post-2030 sustainable development agendaCameron Allen, Shirin Malekpour, Nina Weitz, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXiaohu Zhang, Jaimie K Rueter, Yongsheng Chen, et al.
Journal of Medicinal Chemistry|January 15, 2008
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacyDeborah H Slee, Xiaohu Zhang, Manisha Moorjani, et al.
Journal of Medicinal Chemistry|March 1, 2008
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituentsDeborah H Slee, Yongsheng Chen, Xiaohu Zhang, et al.
Pageof 18